Dendritic cell autophagy contributes to herpes simplex virus- driven stromal keratitis and immunopathology

mBio

Volumn 6, Issue 6, 2015, Pages

  Jiang, Yike ^a   Yin, Xiaotang ^b   Stuart, Patrick M ^b   Leib, David A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; AUTOPHAGY; BLINDNESS; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA; DENDRITIC CELL; DRUG TARGETING; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPETIC STROMAL KERATITIS; HOST; IMMUNOPATHOLOGY; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UNITED STATES; VIRAL CLEARANCE; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ANIMALS; AUTOPHAGY; CD4-POSITIVE T-LYMPHOCYTES; CORNEA; CYTOKINES; DENDRITIC CELLS; HERPESVIRUS 1, HUMAN; IMMUNITY, INNATE; KERATITIS, HERPETIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C;

EID: 84952815300     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01426-15     Document Type: Article

References (91)

1. Liesegang TJ. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13. http://dx.doi.org/10.1097/00003226-200101000-00001.
2. Farooq AV, Shukla D. 2012. Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 57:448-462. http:// dx.doi.org/10.1016/j.survophthal.2012.01.005.
3. Shuster JJ, Kaufman HE, Nesburn AB. 1981. Statistical analysis of the rate of recurrence of herpesvirus ocular epithelial disease. Am J Ophthalmol 91:328-331. http://dx.doi.org/10.1016/0002-9394(81)90285-3.
4. Stanzel TP, Diaz JD, Mather R, Wong IG, Margolis TP, Gritz DC. 2014. The epidemiology of herpes simplex virus eye disease in Northern California. Ophthal Epidemiol 21:370-377. http://dx.doi.org/10.3109/ 09286586.2014.966848.
5. Liesegang TJ, Melton LJ, Daly PJ, Ilstrup DM. 1989. Epidemiology of ocular herpes simplex. Incidence in Rochester, Minn, 1950 through 1982. Arch Ophthalmol 107:1155-1159. http://dx.doi.org/10.1001/ archopht.1989.01070020221029.
6. Young RC, Hodge DO, Liesegang TJ, Baratz KH. 2010. Incidence, recurrence, and outcomes of herpes simplex virus eye disease in Olmsted County, Minnesota, 1976-2007: the effect of oral antiviral prophylaxis. Arch Ophthalmol 128:1178-1183. http://dx.doi.org/10.1001/ archophthalmol.2010.187.
7. Metcalf JF, Hamilton DS, Reichert RW. 1979. Herpetic keratitis in athymic (nude) mice. Infect Immun 26:1164-1171.
8. Russell RG, Nasisse MP, Larsen HS, Rouse BT. 1984. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest Ophthalmol Vis Sci 25:938-944.
9. Hendricks RL, Tumpey TM, Finnegan A. 1992. IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice. J Immunol 149:3023-3028.
10. Hendricks RL, Tumpey TM. 1990. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology. Invest Ophthalmol Vis Sci 31:1929-1939.
11. Wilhelmus KR, Gee L, Hauck WW, Kurinij N, Dawson CR, Jones DB, Barron BA, Kaufman HE, Sugar J, Hyndiuk RA. 1994. Herpetic eye disease study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 101:1883-1895.
12. Renfro L, Snow JS. 1992. Ocular effects of topical and systemic steroids. Dermatol Clin 10:505-512.
13. Tumpey TM, Chen SH, Oakes JE, Lausch RN. 1996. Neutrophilmediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J Virol 70:898-904.
14. Biswas PS, Rouse BT. 2005. Early events in HSV keratitis-setting the stage for a blinding disease. Microbes Infect 7:799-810. http://dx.doi.org/ 10.1016/j.micinf.2005.03.003.
15. Hendricks RL, Tumpey TM. 1991. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr Eye Res 10(Suppl):47-53. http://dx.doi.org/10.3109/02713689109020357.
16. Wuest TR, Carr DJJ. 2010. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J Exp Med 207:101-115. http:// dx.doi.org/10.1084/jem.20091385.
17. Bryant-Hudson KM, Gurung HR, Zheng M, Carr DJJ. 2014. Tumor necrosis factor alpha and interleukin-6 facilitate corneal lymphangiogenesis in response to herpes simplex virus 1 infection. J Virol 88: 14451-14457. http://dx.doi.org/10.1128/JVI.01841-14.
18. Newell CK, Sendele D, Rouse BT. 1989. Effects of CD4+ and CD8+ T-lymphocyte depletion on the induction and expression of herpes simplex stromal keratitis. Reg Immunol 2:366-369.
19. Newell CK, Martin S, Sendele D, Mercadal CM, Rouse BT. 1989. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J Virol 63:769-775.
20. Doymaz MZ, Rouse BT. 1992. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest Ophthalmol Vis Sci 33:2165-2173.
21. Mercadal CM, Bouley DM, DeStephano D, Rouse BT. 1993. Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol 67: 3404-3408.
22. Niemialtowski MG, Rouse BT. 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J Immunol 149:3035-3039.
23. Xia L, Zhang S, Cao Z, Hu Y, Yang H, Wang D. 2013. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis. Microbes Infect 15:126-139. http://dx.doi.org/10.1016/ j.micinf.2012.10.017.
24. Tang Q, Chen W, Hendricks RL. 1997. Proinflammatory functions of IL-2 in herpes simplex virus corneal infection. J Immunol 158:1275-1283.
25. Minami M, Kita M, Yan X, Yamamoto T, Iida T, Sekikawa K, Iwakura Y, Imanishi J. 2002. Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection. J Interferon Cytokine Res 22: 671-676. http://dx.doi.org/10.1089/10799900260100150.
26. Maertzdorf J, Osterhaus AD, Verjans GM. 2002. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J Immunol 169:5897-5903. http:// dx.doi.org/10.4049/jimmunol.169.10.5897.
27. Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. 2004. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172:4123-4132. http://dx.doi.org/ 10.4049/jimmunol.172.7.4123.
28. Nesburn AB, Bettahi I, Dasgupta G, Chentoufi AA, Zhang X, You S, Morishige N, Wahlert AJ, Brown DJ, Jester JV, Wechsler SL, BenMohamed L. 2007. Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virusspecific CD4+ and CD8+ effector T cells during ocular herpes infection. J Virol 81:7647-7661. http://dx.doi.org/10.1128/JVI.00294-07.
29. Veiga-Parga T, Suryawanshi A, Mulik S, Giménez F, Sharma S, Sparwasser T, Rouse BT. 2012. On the role of regulatory T cells during viralinduced inflammatory lesions. J Immunol 189:5924-5933. http:// dx.doi.org/10.4049/jimmunol.1202322.
30. Johnson AJ, Chu C-F, Milligan GN. 2008. Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords. J Virol 82:9678-9688. http://dx.doi.org/10.1128/ JVI.01159-08.
31. Van Velzen M, Jing L, Osterhaus ADME, Sette A, Koelle DM, Verjans GMGM. 2013. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog 9:e1003547. http://dx.doi.org/10.1371/journal.ppat.1003547.
32. Lepisto AJ, Frank GM, Xu M, Stuart PM, Hendricks RL. 2006. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest Ophthalmol Vis Sci 47:3400-3409. http://dx.doi.org/10.1167/ iovs.05-0898.
33. Mastropasqua L, Nubile M, Lanzini M, Carpineto P, Ciancaglini M, Pannellini T, Di Nicola M, Dua HS. 2006. Epithelial dendritic cell distribution in normal and inflamed human cornea: in vivo confocal microscopy study. Am J Ophthalmol 142:736-744. http://dx.doi.org/10.1016/ j.ajo.2006.06.057.
34. Mayer WJ, Irschick UM, Moser P, Wurm M, Huemer HP, Romani N, Irschick EU. 2007. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest Ophthalmol Vis Sci 48:4459-4467. http://dx.doi.org/10.1167/iovs.06-1184.
35. Paludan C, Schmid D, Landthaler M, Vockerodt M, Kube D, Tuschl T, Münz C. 2005. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307:593-596. http://dx.doi.org/10.1126/ science.1104904.
36. Schmid D, Pypaert M, Münz C. 2007. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26:79-92. http:// dx.doi.org/10.1016/j.immuni.2006.10.018.
37. Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, Mizushima N, Grinstein S, Iwasaki A. 2010. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32:227-239. http:// dx.doi.org/10.1016/j.immuni.2009.12.006.
38. Reed M, Morris SH, Jang S, Mukherjee S, Yue Z, Lukacs NW. 2013. Autophagy-inducing protein beclin-1 in dendritic cells regulates CD4 T cell responses and disease severity during respiratory syncytial virus infection. J Immunol 191:2526-2537. http://dx.doi.org/10.4049/ jimmunol.1300477.
39. Bhattacharya A, Parillon X, Zeng S, Han S, Eissa NT. 2014. Deficiency of autophagy in dendritic cells protects against experimental autoimmune encephalomyelitis. J Biol Chem 289:26525-26532. http://dx.doi.org/ 10.1074/jbc.M114.575860.
40. Kuma A, Mizushima N, Ishihara N, Ohsumi Y. 2002. Formation of the approximately 350-kDa Apg12-Apg5.Apg16 multimeric complex, medi-ated by Apg16 oligomerization, is essential for autophagy in yeast. J Biol Chem 277:18619-18625. http://dx.doi.org/10.1074/jbc.M111889200.
41. Mizushima N, Noda T, Yoshimori T, Tanaka Y, Ishii T, George MD, Klionsky DJ, Ohsumi M, Ohsumi Y. 1998. A protein conjugation system essential for autophagy. Nature 395:395-398. http://dx.doi.org/10.1038/ 26506.
42. Mizushima N, Ohsumi Y, Yoshimori T. 2002. Autophagosome formation in mammalian cells. Cell Struct Funct 27:421-429. http://dx.doi.org/ 10.1247/csf.27.421.
43. Frank GM, Buela K-G, Maker DM, Harvey SAK, Hendricks RL. 2012. Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J Immunol 188: 1350-1359. http://dx.doi.org/10.4049/jimmunol.1101968.
44. Shen FH, Wang SW, Yeh TM, Tung YY, Hsu SM, Chen SH. 2013. Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice. J Virol 87:8502-8510. http://dx.doi.org/ 10.1128/JVI.01198-13.
45. Fischer MA, Davies ML, Reider IE, Heipertz EL, Epler MR, Sei JJ, Ingersoll MA, Van Rooijen N, Randolph GJ, Norbury CC. 2011. CD11b+, Ly6G+ cells produce type I interferon and exhibit tissue protective properties following peripheral virus infection. PLoS Pathog 7:e1002374. http://dx.doi.org/10.1371/journal.ppat.1002374.
46. Gobeil PAM, Leib DA. 2012. Herpes simplex virus γ34.5 interferes with autophagosome maturation and antigen presentation in dendritic cells. mBio 3:e00267-12. http://dx.doi.org/10.1128/mBio.00267-12.
47. Liu E, Van Grol J, Subauste CS. 2015. ATG5 but not ATG7 in dendritic cells enhances IL-2 and IFN-γ production by Toxoplasma gondii-reactive CD4(+) T cells. Microbes Infect 17:275-284. http://dx.doi.org/10.1016/ j.micinf.2014.12.008.
48. Kaye S, Choudhary A. 2006. Herpes simplex keratitis. Prog Retin Eye Res 25:355-380. http://dx.doi.org/10.1016/j.preteyeres.2006.05.001.
49. Sugar A. 2014. Herpes simplex keratitis. UpToDate http:// www.uptodate.com/contents/herpes-simplex-keratitis.
50. Kassim SH, Rajasagi NK, Zhao X, Chervenak R, Jennings SR. 2006. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 80:3985-3993. http://dx.doi.org/10.1128/JVI.80.8.3985-3993.2006.
51. Hendricks RL, Janowicz M, Tumpey TM. 1992. Critical role of corneal Langerhans cells in the CD4-but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J Immunol 148: 2522-2529.
52. Knickelbein JE, Buela K, Hendricks RL. 2014. Antigen-presenting cells are stratified within normal human corneas and are rapidly mobilized during ex vivo viral infection. Invest Ophthalmol Vis Sci 55:1118-1123. http://dx.doi.org/10.1167/iovs.13-13523.
53. Buela K-G, Hendricks RL. 2015. Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection. J Immunol 194:379-387. http://dx.doi.org/ 10.4049/jimmunol.1402326.
54. Mansur DS, Kroon EG, Nogueira ML, Arantes RME, Rodrigues SCO, Akira S, Gazzinelli RT, Campos MA. 2005. Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol 166:1419-1426. http://dx.doi.org/10.1016/S0002-9440(10)62359-0.
55. Vollstedt S, Arnold S, Schwerdel C, Franchini M, Alber G, Di Santo JP, Ackermann M, Suter M. 2004. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 78:3846-3850. http://dx.doi.org/10.1128/ JVI.78.8.3846-3850.2004.
56. Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku C-L, Casrouge A, Zhang X-X, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova JL. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527. http:// dx.doi.org/10.1126/science.1139522.
57. Lafaille FG, Pessach IM, Zhang S, Ciancanelli MJ, Herman M, Abhyankar A, Ying S, Keros S, Goldstein PA, Mostoslavsky G, Ordovas-Montanes J, Jouanguy E, Plancoulaine S, Tu E, Elkabetz Y, Al-Muhsen S, Tardieu M, Schlaeger TM, Daley GQ, Abel L, Casanova J-L, Studer L, Notarangelo LD. 2012. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491:769-773. http:// dx.doi.org/10.1038/nature11583.
58. Casrouge A, Zhang S-Y, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL. Héron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova J-L. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308-312. http:// dx.doi.org/10.1126/science.1128346.
59. Parr MB, Parr EL. 2003. Intravaginal administration of herpes simplex virus type 2 to mice leads to infection of several neural and extraneural sites. J Neurovirol 9:594-602. http://dx.doi.org/10.1080/jnv.9.6.594.602.
60. Morahan PS, Breinig MC, McGeorge MB. 1977. Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2. J Immunol 119:2030-2036.
61. Lee S, Ives AM, Bertke AS. 2015. HSV-1 reactivates from autonomic ciliary ganglia independently from sensory trigeminal ganglia to cause recurrent ocular disease. J Virol 89:8383-8391. http://dx.doi.org/10.1128/ JVI.00468-15.
62. Kintner RL, Brandt CR. 1995. The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Curr Eye Res 14:145-152. http://dx.doi.org/ 10.3109/02713689508999926.
63. Richards JT, Kern ER, Overall JC, Glasgow LA. 1981. Differences in neurovirulence among isolates of herpes simplex virus types 1 and 2 in mice using four routes of infection. J Infect Dis 144:464-471. http:// dx.doi.org/10.1093/infdis/144.5.464.
64. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. 1996. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol 70:101-107.
65. Stuart PM, Summers B, Morris JE, Morrison LA, Leib DA. 2004. CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J Gen Virol 85:2055-2063. http://dx.doi.org/ 10.1099/vir.0.80049-0.
66. Ravindran R, Khan N, Nakaya HI, Li S, Loebbermann J, Maddur MS, Park Y, Jones DP, Chappert P, Davoust J, Weiss DS, Virgin HW, Ron D, Pulendran B. 2014. Vaccine activation of the nutrient sensor GCN2 in dendritic cells enhances antigen presentation. Science 343:313-317. http://dx.doi.org/10.1126/science.1246829.
67. Mintern JD, Macri C, Chin WJ, Panozza SE, Segura E, Patterson NL, Zeller P, Bourges D, Bedoui S, McMillan PJ, Idris A, Nowell CJ, Brown A, Radford KJ, Johnston AP, Villadangos JA. 2015. Differential use of autophagy by primary dendritic cells specialized in cross-presentation. Autophagy 11:906-917. http://dx.doi.org/10.1080/15548627.2015.1045178.
68. Sehrawat S, Suvas S, Sarangi PP, Suryawanshi A, Rouse BT. 2008. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J Virol 82:6838-6851. http://dx.doi.org/10.1128/ JVI.00697-08.
69. Gaddipati S, Estrada K, Rao P, Jerome AD, Suvas S. 2015. IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis. J Immunol 194:273-282. http:// dx.doi.org/10.4049/jimmunol.1401285.
70. Staats HF, Lausch RN. 1993. Cytokine expression in vivo during murine herpetic stromal keratitis. Effect of protective antibody therapy. J Immunol 151:277-283.
71. Arrunategui-Correa V, Baltatzis S, Foster CS. 1999. The role of cytokines in experimental herpes simplex keratitis. Acta Virol 43:325-329.
72. Lee SK, Choi BK, Kang WJ, Kim YH, Park HY, Kim KH, Kwon BS. 2008. MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol Cells 26:67-73.
73. Heiligenhaus A, Foster CS. 1994. Histological and immunopathological analysis of T-cells mediating murine HSV-1 keratitis. Graefes Arch Clin Exp Ophthalmol 232:628-634. http://dx.doi.org/10.1007/BF00193124.
74. Thomas J, Gangappa S, Kanangat S, Rouse BT. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J Immunol 158:1383-1391.
75. Tang Q, Hendricks RL. 1996. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J Exp Med 184:1435-1447. http://dx.doi.org/10.1084/jem.184.4.1435.
76. Opremcak EM, Rice BA, Wells PA, Foster CS. 1990. Histology and immunohistology of Igh-1-restricted herpes simplex keratitis in BALB/c congenic mice. Invest Ophthalmol Vis Sci 31:305-312.
77. Labetoulle M, Auquier P, Conrad H, Crochard A, Daniloski M, Bouée S, Elhasnaoui A, Colin J. 2005. Incidence of herpes simplex virus keratitis in France. Ophthalmology 112:888-895. http://dx.doi.org/10.1016/ j.ophtha.2004.11.052.
78. Neumann J, Eis-Hübinger AM, Koch N. 2003. Herpes simplex virus type 1 targets theMHCclass II processing pathway for immune evasion. J Immunol 171:3075-3083. http://dx.doi.org/10.4049/jimmunol.171.6.3075.
79. Rader KA, Ackland-Berglund CE, Miller JK, Pepose JS, Leib DA. 1993. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J Gen Virol 74:1859-1869. http://dx.doi.org/10.1099/0022-1317-74-9-1859.
80. Brown SM, Ritchie DA, Subak-Sharpe JH. 1973. Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J Gen Virol 18:329-346. http:// dx.doi.org/10.1099/0022-1317-18-3-329.
81. Williams LE, Nesburn AB, Kaufman HE. 1965. Experimental induction of disciform keratitis. Arch Ophthalmol 73:112-114. http://dx.doi.org/ 10.1001/archopht.1965.00970030114023.
82. Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N. 2006. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441:885-889. http://dx.doi.org/ 10.1038/nature04724.
83. Caton ML, Smith-Raska MR, Reizis B. 2007. Notch-RBP-J signaling controls the homeostasis of CD8+ dendritic cells in the spleen. J Exp Med 204:1653-1664. http://dx.doi.org/10.1084/jem.20062648.
84. Madsen L, Labrecque N, Engberg J, Dierich A, Svejgaard A, Benoist C, Mathis D, Fugger L. 1999. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A 96:10338-10343. http://dx.doi.org/ 10.1073/pnas.96.18.10338.
85. West DM, Del Rosso CR, Yin X, Stuart PM. 2014. CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis. J Immunol 192: 1762-1767. http://dx.doi.org/10.4049/jimmunol.1302957.
86. Leib DA, Coen DM, Bogard CL, Hicks KA, Yager DR, Knipe DM, Tyler KL, Schaffer PA. 1989. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol 63:759-768.
87. Divito SJ, Hendricks RL. 2008. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest Ophthalmol Vis Sci 49:1488-1495. http://dx.doi.org/10.1167/iovs.07-1107.
88. Patankar YR, Lovewell RR, Poynter ME, Jyot J, Kazmierczak BI, Berwin B. 2013. Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa. Infect Immun 81: 2043-2052. http://dx.doi.org/10.1128/IAI.00054-13.
89. Amiel E, Alonso A, Uematsu S, Akira S, Poynter ME, Berwin B. 2009. Pivotal advance: Toll-like receptor regulation of scavenger receptor-Amediated phagocytosis. J Leukoc Biol 85:595-605. http://dx.doi.org/ 10.1189/jlb.1008631.
90. Rowe AM, St. Leger AJ, Jeon S, Dhaliwal DK, Knickelbein JE, Hendricks RL. 2013. Herpes keratitis. Prog Retin Eye Res 32:88-101. http:// dx.doi.org/10.1016/j.preteyeres.2012.08.002.
91. Rubinsztein DC, Codogno P, Levine B. 2012. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat Rev Drug Discov 11:709-730. http://dx.doi.org/10.1038/nrd3802.